Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Contieri

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
Nature Reviews. Urology|April 1, 2026
Active surveillance in low-grade NMIBC - results of an international two-round modified Delphi consensusRoberto Contieri, Paolo Gontero, Rodolfo Hurle, et al.
World Journal of Urology|June 10, 2026
Nephroureterectomy for upper tract urothelial carcinoma recurrence in bladder cancer patients treated with radical cystectomy: a multicentric propensity score matched analysis on predictors, practice patterns and survival outcomesValerio Santarelli, Vincenzo Asero, Roberta Corvino, et al.
BJU International|June 25, 2025
Enhanced prognostic value of four-tier hybrid grading system in Ta non-muscle-invasive bladder cancerMatteo Ferro, Michele Catellani, Roberto Bianchi, et al.
Cancers|November 13, 2021
The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort AnalysisMatteo Ferro, Francesco Del Giudice, Giuseppe Carrieri, et al.
International Urology and Nephrology|January 3, 2026
Defining the optimal duration of maintenance mitomycin C in intermediate-risk Ta NMIBC: a multicenter retrospective landmark analysisRoberto Contieri, Letizia Maria Ippolita Jannello, Mihai Dorin Vartolomei, et al.
BJU International|August 29, 2025
Defining statistical cure in patients with T1 high-grade non-muscle-invasive bladder carcinoma treated with BCG immunotherapyJosé Daniel Subiela, Irene de la Parra, Javier Taborda, et al.
International Urology and Nephrology|November 19, 2023
Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?Irene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
European Urology Oncology|May 21, 2025
Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non-muscle-invasive Bladder CancerRoberto Contieri, Alberto Martini, Irene J Beijert, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Nature Reviews. Urology|April 1, 2026
Active surveillance in low-grade NMIBC - results of an international two-round modified Delphi consensusRoberto Contieri, Paolo Gontero, Rodolfo Hurle, et al.
World Journal of Urology|June 10, 2026
Nephroureterectomy for upper tract urothelial carcinoma recurrence in bladder cancer patients treated with radical cystectomy: a multicentric propensity score matched analysis on predictors, practice patterns and survival outcomesValerio Santarelli, Vincenzo Asero, Roberta Corvino, et al.
BJU International|June 25, 2025
Enhanced prognostic value of four-tier hybrid grading system in Ta non-muscle-invasive bladder cancerMatteo Ferro, Michele Catellani, Roberto Bianchi, et al.
Cancers|November 13, 2021
The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort AnalysisMatteo Ferro, Francesco Del Giudice, Giuseppe Carrieri, et al.
International Urology and Nephrology|January 3, 2026
Defining the optimal duration of maintenance mitomycin C in intermediate-risk Ta NMIBC: a multicenter retrospective landmark analysisRoberto Contieri, Letizia Maria Ippolita Jannello, Mihai Dorin Vartolomei, et al.
BJU International|August 29, 2025
Defining statistical cure in patients with T1 high-grade non-muscle-invasive bladder carcinoma treated with BCG immunotherapyJosé Daniel Subiela, Irene de la Parra, Javier Taborda, et al.
International Urology and Nephrology|November 19, 2023
Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?Irene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
European Urology Oncology|May 21, 2025
Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non-muscle-invasive Bladder CancerRoberto Contieri, Alberto Martini, Irene J Beijert, et al.
Pageof 14